SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Allergan Inc.  (AGN) Trade Now »     Rate AGN  -  Discuss AGN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
96.5%
Top:
100.0%
Rate AGN:



AGN Analysis & Videos »


AGN: Bull or Bear?

Cosmetic & Reconstructive Medicine: An Industry Profile Graphic_rating_buy AGN
Rxlogo
75%
 -9.64%
in 53 days

Cosmetic & Reconstructive Medicine : An Industry Profile

Cosmetic & Reconstructive Medicine Index
Top 5 Companies by Market Cap
Top 5 Companies by 52-Week Stock Price Change


The accompanying tables present an overview of my 48-company Global Cosmetic and Reconstructive Medicine (CRM) Index which includes companies engaged in skin care, cosmetic medicine, regenerative medicine, orthopedic repair, and joint replacements. The performance over the past year of my CRM Index compares favorably to benchmark ETFs such as HealthShares C
...
By  Mike Havrilla   (-3.61%  risk: moderate)  10/12/08 Comment


Allergan Inc. Graphic_rating_buy AGN
Foto
66%
 -28.71%
in 150 days
Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for glaucoma therapy, ocular inflammation, infection, allergy, and chron...
By  Marian Filo   (-31.45%  risk: aggressive)  07/07/08 Comment


Allergan Premium Makes It a Hold AGN
-29.93%
in 163 days
We believe these acquisitions will provide Allergan with the opportunity to drive growth in its existing business and to expand into new areas of business.
By  Zacks.com   (-25.21%  risk: conservative)  06/24/08 Comment


Get free stock alert for AGN:
Your Email Address:


Cramer on BloggingStocks: Europe is starting to eye U.S. gems Graphic_rating_buy AGN
-31.08%
in 210 days

Filed under: Deals, Market matters, Allergan (AGN), Citigroup Inc. (C), Sprint Nextel Corp (S), Unilever ADR (UL), Stocks to Buy, Cramer on BloggingStocks

TheStreet.com's Jim Cramer says the exchange rate plus massive undervaluations make the great brands prime targets.

There's always been a groupthink in Europe about currencies. The companies that want to buy American companies have, at times, seemed to care more about the currency, or at least not buying a company in a country whose currency is in decline, than they care about the actual target.

That's what it looks like now that a lar...
By  Jim Cramer   (-19.87%  risk: conservative)  05/08/08 Comment





People Bullish on AGN

Statistician
Analyst
N/A
about 15 hours ago

Art
Analyst
N/A
about 22 hours ago

Rxlogo
Mike Havrilla
Principal
75%
about 1 mo ago

kiltman
Analyst
52%
4 mos ago

Foto
Marian Filo
Principal
66%
5 mos ago


People Bearish on AGN

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 19.61 +43.19% 175
2 Gerald Greene 18.26 +42.29% 57
3 krprasad 16.35 +17.71% 7
4 The Big Bear 14.95 +39.54% 212
5 akiralegrand 13.77 +16.71% 40


POPULAR STOCKS
Symbol Company Name Sentiment
WMT WalMart Stores Inc
DELL Dell Inc
CSCO Cisco Systems Inc
AAPL Apple Computer Inc
GS Goldman Sachs Group Inc The
MA MasterCard Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 


StreetInsider.com on AGN


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Allergan Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch